A rheumatologist explains the differences between biologics and highly similar drugs called biosimilars to treat inflammatory types of arthritis.

Expert:
Angus Worthing, MD, Arthritis & Rheumatism Associates, PC, Chair of Policy, DC Rheumatism Society

For more information about Biosimilars, watch our full webinar: [ Ссылка ]

For more information on the Arthritis Foundations statement about Biosimilars, check out: [ Ссылка ]

Ten Things You Should Know About Biologics & Biosimilars: [ Ссылка ]

Questions to Ask Your Doctor About Biologics & Biosimilars: [ Ссылка ]

This webinar was recorded on Wednesday, November 9th, 2022.

свернуть